Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07436351 · ClinicalTrials.gov registry record · NA
ACT With CF Self-Help Toolkit
A NA study of Cystic Fibrosis (CF) and Depressive and Anxiety Disorders, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07436351: Recruiting NA study of Cystic Fibrosis (CF) and Depressive and Anxiety Disorders, sponsored by Thomas Jefferson University.
NCT07436351 is a NA study of Cystic Fibrosis (CF) and Depressive and Anxiety Disorders that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 60 participants, below the 137-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07436351, a NA study of Cystic Fibrosis (CF) and Depressive and Anxiety Disorders, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depression and improve psychological flexibility, and value-based living. The investigators are now trying to find out whether a self-help version of this treatment (ACT with CF - Self Help Toolkit) is also effective in reducing anxiety and depression and improving psychological flexibility and value-based living in adults with CF. Adults with cystic fibrosis are at increased risk for anxiety and depression. This study examines whether a patient-facing therapy, ACT with CF - Self Help Toolkit can help to reduce anxiety and depression among adults with CF. This treatment can be accessed on the participant's smartphone.
Primary Outcome
Anxiety as measured by the Beck Anxiety Inventory (Range 0-63), with higher values indicating higher anxiety.
Conditions Studied
Interventions
- BEHAVIORAL ACT with CF Self-Help Toolkit
- OTHER Waitlist
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2027-04 |
| Phase | NA |
What NCT07436351 shows while recruiting
NCT07436351 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 137-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (56% lower).
The record links to 3 conditions, with Cystic Fibrosis (CF) appearing as the primary indexed condition, and to 2 interventions - of which ACT with CF Self-Help Toolkit is the first listed.
NCT07436351 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07436351 about?
NCT07436351 is a clinical study titled "ACT With CF Self-Help Toolkit". Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depression and improve psychological flexibility, and value-based living. The investigators are now trying t...
What is the current status of trial NCT07436351?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-20. Estimated completion is 2027-04.
What conditions does trial NCT07436351 study?
This clinical trial studies the following conditions: Cystic Fibrosis (CF), Depressive and Anxiety Disorders, Psychological Flexibility.
What interventions are being tested in trial NCT07436351?
The interventions under investigation include: ACT with CF Self-Help Toolkit (BEHAVIORAL), Waitlist (OTHER).
Who is sponsoring clinical trial NCT07436351?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07436351 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis (CF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07436351's enrollment target sits among peer trials
60 11th of 14 higher than 3 of 14 other Cystic Fibrosis (CF) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cystic Fibrosis (CF) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
RECRUITING · NA
-
CF Wellness Program
RECRUITING · NA
-
OnTrackCF: Engagement, Feasibility, and Acceptability Study
RECRUITING · NA
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
RECRUITING
-
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI